Skip to main content

Advertisement

SpringerLink
Log in

Current trends in initial management of laryngeal cancer: the declining use of open surgery

  • Review Article
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

The role of open surgery for management of laryngeal cancer has been greatly diminished during the past decade. The development of transoral endoscopic laser microsurgery (TLS), improvements in delivery of radiation therapy (RT) and the advent of multimodality protocols, particularly concomitant chemoradiotherapy (CCRT) have supplanted the previously standard techniques of open partial laryngectomy for early cancer and total laryngectomy followed by adjuvant RT for advanced cancer. A review of the recent literature revealed virtually no new reports of conventional conservation surgery as initial treatment for early stage glottic and supraglottic cancer. TLS and RT, with or without laser surgery or CCRT, have become the standard initial treatments for T1, T2 and selected T3 laryngeal cancer. Photodynamic therapy (PDT) may have an emerging role in the treatment of early laryngeal cancer. Anterior commissure involvement presents particular difficulties in application of TLS, although no definitive conclusions have been reached with regard to optimal treatment of these lesions. Results of TLS are equivalent to those obtained by conventional conservation surgery, with considerably less morbidity, less hospital time and better postoperative function. Oncologic results of TLS and RT are equivalent for glottic cancer, but with better voice results for RT in patients who require more extensive cordectomy. The preferred treatment for early supraglottic cancer, particularly for bulkier or T3 lesions is TLS, with or without postoperative RT. The Veterans Administration Study published in 1991 established the fact that the response to neoadjuvant CT predicts the response of a tumor to RT. Patients with advanced tumors that responded either partially or completely to CT were treated with RT, and total laryngectomy was reserved for non-responders. This resulted in the ability to preserve the larynx in a significant number of patients with locally advanced laryngeal cancer, while achieving local control and overall survival results equivalent to those achieved with initial total laryngectomy. Following this report, similar “organ preservation” protocols were employed in many centers. By 2003, results of the RTOG 93-11 trial, utilizing CCRT as initial treatment, were published, demonstrating a higher rate of laryngeal preservation with this protocol. Surgery was reserved for treatment failures. This concept changed the paradigm for management of advanced laryngeal cancer, greatly reducing the number of laryngectomies performed. While supracricoid laryngectomy has been employed for selected patients, total laryngectomy is the usual procedure for salvage of failure after non-surgical treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Holsinger FC (2008) Swing of the pendulum: optimizing functional outcomes in larynx cancer. Curr Oncol Rep 10:170–175

    Article  PubMed  Google Scholar 

  2. Ferlito A, Carbone A, Rinaldo A, Ferlito A, DeSanto LW, D’Angelo L, Barnes L, Devaney KO (1996) “Early” cancer of the larynx: the concept as defined by clinicians, pathologists, and biologists. Ann Otol Rhinol Laryngol 105:245–250

    PubMed  CAS  Google Scholar 

  3. American Society of Clinical Oncology, Pfister DG, Laurie SA, Weinstein GS, Mendenhall WM, Adelstein DJ, Ang KK, Clayman GL, Fisher SG, Forastiere AA, Harrison LB, Lefebvre JL, Leupold N, List MA, O’Malley BO, Patel S, Posner MR, Schwartz MA, Wolf GT (2006) American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 24:3693–3704

    Article  PubMed  Google Scholar 

  4. Foote RL, Brown PD, Garces YI, Okuno SH, Miller RC, Strome SE (2007) Informed consent in advanced laryngeal cancer. Head Neck 29:230–235

    Article  PubMed  Google Scholar 

  5. Sanderson RJ, Montague ML (2004) Surgical management of head and neck malignancy. Surgeon 2:7–14

    Article  PubMed  CAS  Google Scholar 

  6. Ferlito A, Rinaldo A, Silver CE, Robbins KT, Medina JE, Rodrigo JP, Shaha AR, Takes RP, Bradley PJ (2008) Neck dissection for laryngeal cancer. J Am Coll Surg 207:587–593

    Article  PubMed  Google Scholar 

  7. Steiner W (1993) Results of curative laser microsurgery of laryngeal carcinomas. Am J Otolaryngol 14:116–121

    Article  PubMed  CAS  Google Scholar 

  8. Eckel HE, Thumfart WF (1992) Laser surgery for the treatment of larynx carcinomas: indications, techniques, and preliminary results. Ann Otol Rhinol Laryngol 101:113–118

    PubMed  CAS  Google Scholar 

  9. Eckel HE, Schneider C, Jungehülsing M, Damm M, Schröder U, Vössing M (1998) Potential role of transoral laser surgery for larynx carcinoma. Lasers Surg Med 23:79–86

    Article  PubMed  CAS  Google Scholar 

  10. Rudert HH, Werner JA, Höft S (1999) Transoral carbon dioxide laser resection of supraglottic carcinoma. Ann Otol Rhinol Laryngol 108:819–827

    PubMed  CAS  Google Scholar 

  11. Iro H, Waldfahrer F, Altendorf-Hofmann A, Weidenbecher M, Sauer R, Steiner W (1998) Transoral laser surgery of supraglottic cancer: follow-up of 141 patients. Arch Otolaryngol Head Neck Surg 124:1245–1250

    PubMed  CAS  Google Scholar 

  12. Ambrosch P (2007) The role of laser microsurgery in the treatment of laryngeal cancer. Curr Opin Otolaryngol Head Neck Surg 15:82–88

    Article  PubMed  Google Scholar 

  13. Remacle M, Eckel HE, Antonelli A, Brasnu D, Chevalier D, Friedrich G, Olofsson J, Rudert HH, Thumfart W, de Vincentiis M, Wustrow TP (2000) Endoscopic cordectomy. A proposal for a classification by the Working Committee, European Laryngological Society. Eur Arch Otorhinolaryngol 257:227–231

    Article  PubMed  CAS  Google Scholar 

  14. Remacle M, Van Haverbeke C, Eckel H, Bradley P, Chevalier D, Djukic V, de Vicentiis M, Friedrich G, Olofsson J, Peretti G, Quer M, Werner J (2007) Proposal for revision of the European Laryngological Society classification of endoscopic cordectomies. Eur Arch Otorhinolaryngol 264:499–504

    Article  PubMed  Google Scholar 

  15. Hartl DM, de Monès E, Hans S, Janot F, Brasnu D (2007) Treatment of early-stage glottic cancer by transoral laser resection. Ann Otol Rhinol Laryngol 116:832–836

    PubMed  Google Scholar 

  16. Sjögren EV, Langeveld TP, Baatenburg de Jong RJ (2008) Clinical outcome of T1 glottic carcinoma since the introduction of endoscopic CO2 laser surgery as treatment option. Head Neck 30:1167–1174

    Article  PubMed  Google Scholar 

  17. Grant DG, Salassa JR, Hinni ML, Pearson BW, Hayden RE, Perry WC (2007) Transoral laser microsurgery for untreated glottic carcinoma. Otolaryngol Head Neck Surg 137:482–486

    Article  PubMed  Google Scholar 

  18. Thurnher D, Erovic BM, Frommlet F, Brannath W, Ehrenberger K, Jansen B, Selzer E, Grasl MC (2008) Challenging a dogma—surgery yields superior long-term results for T1a squamous cell carcinoma of the glottic larynx compared to radiotherapy. Eur J Surg Oncol 34:692–698

    PubMed  CAS  Google Scholar 

  19. Dey P, Arnold D, Wight R, MacKenzie K, Kelly C, Wilson J (2002) Radiotherapy versus open surgery versus endolaryngeal surgery (with or without laser) for early laryngeal squamous cell cancer. Cochrane Database Syst Rev 2:CD002027

    PubMed  Google Scholar 

  20. Baron I, Remacle M (2008) Current options in the management of early primary laryngeal cancers. J ENT Mastercl 1:116–120

    Google Scholar 

  21. Bradley PJ, Rinaldo A, Suárez C, Shaha AR, Leemans CR, Langendijk JA, Patel SG, Ferlito A (2006) Primary treatment of the anterior vocal commissure squamous carcinoma. Eur Arch Otorhinolaryngol 263:879–888

    Article  PubMed  Google Scholar 

  22. Mendenhall WM, Amdur RJ, Morris CG, Hinerman RW (2001) T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol 19:4029–4036

    PubMed  CAS  Google Scholar 

  23. Kirchner JA, Fischer JJ (1975) Anterior commissure cancer—a clinical and laboratory study of 39 cases. Can J Otolaryngol 4:637–643

    PubMed  CAS  Google Scholar 

  24. Meyer-Breiting E, Burkhardt A (1988) Tumours of the larynx: histopathology and clinical inferences. Springer, Berlin

    Google Scholar 

  25. Beitler JJ, Johnson JT (2003) Transoral laser excision for early glottic cancer. Int J Radiat Oncol Biol Phys 56:1063–1066

    Article  PubMed  Google Scholar 

  26. Wolfensberger M, Dort JC (1990) Endoscopic laser surgery for early glottic carcinoma: a clinical and experimental study. Laryngoscope 100:1100–1105

    Article  PubMed  CAS  Google Scholar 

  27. Chone CT, Yonehara E, Martins JE, Altemani A, Crespo AN (2007) Importance of anterior commissure in recurrence of early glottic cancer after laser endoscopic resection. Arch Otolaryngol Head Neck Surg 133:882–887

    Article  PubMed  Google Scholar 

  28. Krespi YP, Meltzer CJ (1989) Laser surgery for vocal cord carcinoma involving the anterior commissure. Ann Otol Rhinol Laryngol 98:105–109

    PubMed  CAS  Google Scholar 

  29. Casiano RR, Cooper JD, Lundy DS, Chandler JR (1991) Laser cordectomy for T1 glottic carcinoma: a 10-year experience and videostroboscopic findings. Otolaryngol Head Neck Surg 104:831–837

    PubMed  CAS  Google Scholar 

  30. Pradhan SA, Pai PS, Neeli SI, D’Cruz AK (2003) Transoral laser surgery for early glottic cancers. Arch Otolaryngol Head Neck Surg 129:623–625

    Article  PubMed  Google Scholar 

  31. Rödel RMW, Steiner W, Müller RM, Kron M, Matthias C (2009) Endoscopic laser surgery of early glottic cancer: involvement of the anterior commissure. Head Neck 31:583–592

    Article  PubMed  Google Scholar 

  32. Steiner W, Ambrosch P, Rödel RM, Kron M (2004) Impact of anterior commissure involvement on local control of early glottic carcinoma treated by laser microresection. Laryngoscope 114:1485–1491

    Article  PubMed  Google Scholar 

  33. Steiner W, Ambrosch P (2000) Endoscopic laser surgery of the upper aerodigestive tract. Thieme, Stuttgart, pp 56–60

    Google Scholar 

  34. Laccourreye O, Weinstein G, Brasnu D, Trotoux J, Laccourreye H (1991) Vertical partial laryngectomy: a critical analysis of local recurrence. Ann Otol Rhinol Laryngol 100:68–71

    PubMed  CAS  Google Scholar 

  35. Herranz J, Gavilán J, Vázquez-Barros JC (2007) Carcinoma of the anterior commissure (in Spanish). Acta Otorrinolaringol Esp 58:367–370

    Article  PubMed  Google Scholar 

  36. Bradley PJ, Ferlito A, Suárez C, Werner JA, Genden EM, Shaha AR, Leemans CR, Langendijk JA, Rinaldo A (2006) Options for salvage after failed initial treatment of anterior vocal commissure squamous carcinoma. Eur Arch Otorhinolaryngol 263:889–894

    Article  PubMed  Google Scholar 

  37. Vilaseca I, Huerta P, Blanch JL, Fernández-Planas AM, Jiménez C, Bernal-Sprekelsen M (2008) Voice quality after CO2 laser cordectomy—what can we really expect? Head Neck 30:43–49

    Article  PubMed  Google Scholar 

  38. Manola M, Moscillo L, Costa G, Barillari U, Lo Sito S, Mastella A, Ionna F (2008) Conservative laser microsurgery for T1 glottic carcinoma. Auris Nasus Larynx 35:141–147

    Article  PubMed  CAS  Google Scholar 

  39. Xu W, Han D, Hou L, Zhang L, Yu Z, Huang Z (2007) Voice function following CO2 laser microsurgery for precancerous and early-stage glottic carcinoma. Acta Otolaryngol 127:637–641

    Article  PubMed  Google Scholar 

  40. Motta S, Cesari U, Mesolella M, Motta G (2008) Functional vocal results after CO2 laser endoscopic surgery for glottic tumours. J Laryngol Otol 122:948–951

    Article  PubMed  CAS  Google Scholar 

  41. Piazza C, Bolzoni Villaret A, Redaelli De Zinis LO, Cattaneo A, Cocco D, Peretti G (2007) Phonosurgery after endoscopic cordectomies. II. Delayed medialization techniques for major glottic incompetence after total and extended resections. Eur Arch Otorhinolaryngol 264:1185–1190

    Article  PubMed  Google Scholar 

  42. Núñez Batalla F, Caminero Cueva MJ, Señaris González B, Llorente Pendás JL, Gorriz Gil C, López Llames A, Alonso Pantiga R, Suárez Nieto C (2008) Voice quality after endoscopic laser surgery and radiotherapy for early glottic cancer: objective measurements emphasizing the Voice Handicap Index. Eur Arch Otorhinolaryngol 265:543–548

    Article  PubMed  Google Scholar 

  43. Biel MA (2007) Photodynamic therapy treatment of early oral and laryngeal cancers. Photochem Photobiol 83:1063–1068

    Article  PubMed  CAS  Google Scholar 

  44. Rodrigo JP, Suárez C, Silver CE, Rinaldo A, Ambrosch P, Fagan JJ, Genden EM, Ferlito A (2008) Transoral laser surgery for supraglottic cancer. Head Neck 30:658–666

    Article  PubMed  Google Scholar 

  45. Ambrosch P, Kron M, Steiner W (1998) Carbon dioxide laser microsurgery for early supraglottic carcinoma. Ann Otol Rhinol Laryngol 107:680–688

    PubMed  CAS  Google Scholar 

  46. Zeitels SM, Koufman JA, Davis RK, Vaughan CW (1994) Endoscopic treatment of supraglottic and hypopharynx cancer. Laryngoscope 104:71–78

    Article  PubMed  CAS  Google Scholar 

  47. Davis RK, Kriskovich MD, Galloway EB 3rd, Buntin CS, Jepsen MC (2004) Endoscopic supraglottic laryngectomy with postoperative irradiation. Ann Otol Rhinol Laryngol 113:132–138

    PubMed  Google Scholar 

  48. Ambrosch P, Rödel R, Kron M, Steiner W (2001) Die Transorale lasermikrochirurgie des Larynxkarzinoms. Eine retrospektive Analyse von 657 Patientenverläufen. Der Onkologe 5:505–512

    Article  Google Scholar 

  49. Grant DG, Salassa JR, Hinni ML, Pearson BW, Hayden RE, Perry WC (2007) Transoral laser microsurgery for carcinoma of the supraglottic larynx. Otolaryngol Head Neck Surg 136:900–906

    Article  PubMed  Google Scholar 

  50. Agrawal A, Moon J, Davis RK, Sakr WA, Giri SP, Valentino J, LeBlanc M, Truelson JM, Yoo GH, Ensley JF, Schuller DE (2007) Transoral carbon dioxide laser supraglottic laryngectomy and irradiation in stage I, II, and III squamous cell carcinoma of the supraglottic larynx: report of Southwest Oncology Group Phase 2 Trial S9709. Arch Otolaryngol Head Neck Surg 133:1044–1050

    Article  PubMed  Google Scholar 

  51. Cabanillas R, Rodrigo JP, Llorente JL, Suárez C (2008) Oncologic outcomes of transoral laser surgery of supraglottic carcinoma compared with a transcervical approach. Head Neck 30:750–755

    Article  PubMed  Google Scholar 

  52. Peretti G, Piazza C, Cattaneo A, De Benedetto L, Martin E, Nicolai P (2006) Comparison of functional outcomes after endoscopic versus open-neck supraglottic laryngectomies. Ann Otol Rhinol Laryngol 115:827–832

    PubMed  Google Scholar 

  53. Weinstein GS, O’Malley BW Jr, Snyder W, Hockstein NG (2007) Transoral robotic surgery: supraglottic partial laryngectomy. Ann Otol Rhinol Laryngol 116:19–23

    PubMed  Google Scholar 

  54. Solares CA, Strome M (2007) Transoral robot-assisted CO2 laser supraglottic laryngectomy: experimental and clinical data. Laryngoscope 117:817–820

    Article  PubMed  Google Scholar 

  55. Desai SC, Sung CK, Jang DW, Genden EM (2008) Transoral robotic surgery using a carbon dioxide flexible laser for tumors of the upper aerodigestive tract. Laryngoscope 118:2187–2189

    Article  PubMed  Google Scholar 

  56. Hillel AT, Kapoor A, Simaan N, Taylor RH, Flint P (2008) Applications of robotics for laryngeal surgery. Otolaryngol Clin North Am 41:781–791

    Article  PubMed  Google Scholar 

  57. Ansarin M, Planicka M, Rotundo S, Santoro L, Zurlo V, Maffini F, Alterio D, Cattaneo A, Chiesa F (2007) Endoscopic carbon dioxide laser surgery for glottic cancer recurrence after radiotherapy: oncological results. Arch Otolaryngol Head Neck Surg 133:1193–1197

    Article  PubMed  Google Scholar 

  58. Grant DG, Salassa JR, Hinni ML, Pearson BW, Hayden RE, Perry WC (2008) Transoral laser microsurgery for recurrent laryngeal and pharyngeal cancer. Otolaryngol Head Neck Surg 138:606–613

    Article  PubMed  Google Scholar 

  59. Mendenhall WM, Parsons JT, Stringer SP, Cassisi NJ, Million RR (1988) T1–T2 vocal cord carcinoma. A basis for comparing the results of radiotherapy and surgery. Head Neck Surg 10:373–377

    Article  PubMed  CAS  Google Scholar 

  60. Tamura Y, Tanaka S, Asato R, Hirano S, Yamashita M, Tamaki H, Ito J (2007) Therapeutic outcomes of laryngeal cancer at Kyoto University Hospital for 10 years. Acta Otolaryngol Suppl 557:62–65

    Article  PubMed  Google Scholar 

  61. Overgaard J, Hansen HS, Specht L, Overgaard M, Grau C, Andersen E, Bentzen J, Bastholt L, Hansen O, Johansen J, Andersen L, Evensen JF (2003) Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 362:933–940

    Article  PubMed  Google Scholar 

  62. Schwaibold F, Scariato A, Nunno M, Wallner PE, Lustig RA, Rouby E, Gorshein D, Wenger J (1988) The effect of fraction size on control of early glottic cancer. Int J Radiat Oncol Biol Phys 14:451–454

    PubMed  CAS  Google Scholar 

  63. Garden AS, Forster K, Wong PF, Morrison WH, Schechter NR, Ang KK (2003) Results of radiotherapy for T2N0 glottic carcinoma: does the “2” stand for twice-daily treatment? Int J Radiat Oncol Biol Phys 55:322–328

    PubMed  Google Scholar 

  64. Trotti A, Pajak TF, Emami B, Hammond E, Jones C, Morrison W, Sagar S, Ridge J, Fu KK, Ang K (2006) A randomized trial of hyperfractionation versus standard fractionation in T2 squamous cell carcinoma of the vocal cord. Int J Radiat Oncol Biol Phys 66(Suppl 1):S15

    Google Scholar 

  65. Ohguri T, Imada H, Nakano K, Yahara K, Udaka T, Suzuki H, Korogi Y (2008) Concurrent hyperfractionated radiotherapy and carboplatin with transoral debulking microsurgery for T2N0 glottic cancer. Head Neck 30:1027–1034

    Article  PubMed  Google Scholar 

  66. Niibe Y, Nakayama M, Matsubayashi T, Takahashi H, Kitano M, Okamoto M, Hayakawa K (2007) Effectiveness of concurrent radiation therapy with UFT or TS-1 for T2N0 glottic cancer in Japan. Anticancer Res 27:3497–3500

    PubMed  CAS  Google Scholar 

  67. Hirvikoski P, Virtaniemi J, Kumpulainen E, Johansson R, Kosma VM (2002) Supraglottic and glottic carcinomas: clinically and biologically distinct entities? Eur J Cancer 38:1717–1723

    Article  PubMed  CAS  Google Scholar 

  68. Mendenhall WM, Parsons JT, Stringer SP, Cassisi NJ, Million RR (1990) Carcinoma of the supraglottic larynx: a basis for comparing the results of radiotherapy and surgery. Head Neck 12:204–209

    Article  PubMed  CAS  Google Scholar 

  69. Bhalavat RL, Fakih AR, Mistry RC, Mahantshetty U (2003) Radical radiation vs surgery plus post-operative radiation in advanced (resectable) supraglottic larynx and pyriform sinus cancers: a prospective randomized study. Eur J Surg Oncol 29:750–756

    Article  PubMed  CAS  Google Scholar 

  70. Sessions DG, Lenox J, Spector GJ (2005) Supraglottic laryngeal cancer: analysis of treatment results. Laryngoscope 115:1402–1410

    Article  PubMed  Google Scholar 

  71. Groome PA, O’Sullivan B, Irish JC, Rothwell DM, Schulze K, Warde PR, Schneider KM, Mackenzie RG, Hodson DI, Hammond JA, Gulavita SP, Eapen LJ, Dixon PF, Bissett RJ, Mackillop WJ (2003) Management and outcome differences in supraglottic cancer between Ontario, Canada, and the surveillance, epidemiology, and end results areas of the United States. J Clin Oncol 21:496–505

    Article  PubMed  Google Scholar 

  72. Bhalavat RL, Pathak KA, Mahantshetty U, Jamema SV (2007) Brachytherapy boost: a novel approach for epiglottic carcinoma. Brachytherapy 6:212–217

    Article  PubMed  Google Scholar 

  73. Mendenhall WM, Mancuso AA, Hinerman RW, Malyapa RS, Werning JW, Amdur RJ, Villaret DB (2007) Multidisciplinary management of laryngeal carcinoma. Int J Radiat Oncol Biol Phys 69(Suppl 2):S12–S14

    PubMed  Google Scholar 

  74. Reddy SP, Hong RL, Nagda S, Emami B (2007) Effect of tumor bulk on local control and survival of patients with T1 glottic cancer: a 30-year experience. Int J Radiat Oncol Biol Phys 69:1389–1394

    PubMed  Google Scholar 

  75. Dagan R, Morris CG, Bennett JA, Mancuso AA, Amdur RJ, Hinerman RW, Mendenhall WM (2007) Prognostic significance of paraglottic space invasion in T2N0 glottic carcinoma. Am J Clin Oncol 30:186–190

    Article  PubMed  Google Scholar 

  76. Freeman DE, Mancuso AA, Parsons JT, Mendenhall WM, Million RR (1990) Irradiation alone for supraglottic larynx carcinoma: can CT findings predict treatment results? Int J Radiat Oncol Biol Phys 19:485–490

    PubMed  CAS  Google Scholar 

  77. Mancuso AA (1991) Evaluation and staging of laryngeal and hypopharyngeal cancer by computed tomography and magnetic resonance imaging. In: Silver CE (ed) Laryngeal Cancer. Thieme, New York, pp 46–94

    Google Scholar 

  78. Chang AR, Wu HG, Park CI, Jun YK, Kim CW (2008) Expression of epidermal growth factor receptor and cyclin D1 in pretreatment biopsies as a predictive factor of radiotherapy efficacy in early glottic cancer. Head Neck 30:852–857

    Article  PubMed  Google Scholar 

  79. Lehnerdt GF, Franz P, Winterhoff S, Bankfalvi A, Grehl S, Lang S, Schmid KW, Siffert W, Jahnke K, Frey UH (2008) The GNAS1 T393C polymorphism predicts survival in patients with advanced squamous cell carcinoma of the larynx. Laryngoscope 118:2172–2176

    Article  PubMed  CAS  Google Scholar 

  80. Pai HH, Rochon L, Clark B, Black M, Shenouda G (1998) Overexpression of p53 protein does not predict local-regional control or survival in patients with early-stage squamous cell carcinoma of the glottic larynx treated with radiotherapy. Int J Radiat Oncol Biol Phys 41:37–42

    PubMed  CAS  Google Scholar 

  81. Rydell R, Schalén L, Fex S, Elner A (1995) Voice evaluation before and after laser excision vs. radiotherapy of T1A glottic carcinoma. Acta Otolaryngol 115:560–565

    Article  PubMed  CAS  Google Scholar 

  82. Sjögren EV, van Rossum MA, Langeveld TP, Voerman MS, van de Kamp VA, Friebel MO, Wolterbeek R, Baatenburg de Jong RJ (2008) Voice outcome in T1a midcord glottic carcinoma: laser surgery vs radiotherapy. Arch Otolaryngol Head Neck Surg 134:965–972

    Article  PubMed  Google Scholar 

  83. Bahannan AA, Zábrodsky M, Cerny L, Chovanec M, Lohynska R (2007) Quality of life following endoscopic resection or radio-therapy for early glottic cancer. Saudi Med J 28:598–602

    PubMed  Google Scholar 

  84. Bibby JR, Cotton SM, Perry A, Corry JF (2008) Voice outcomes after radiotherapy treatment for early glottic cancer: assessment using multidimensional tools. Head Neck 30:600–610

    Article  PubMed  Google Scholar 

  85. Hong WK, O’Donoghue GM, Sheetz S, Fofonoff S, Dorman EB, Welch J, Vaughan CW, Karp DD, Willett B, Strong S (1985) Sequential response patterns to chemotherapy and radiotherapy in head and neck cancer: potential impact of treatment in advanced laryngeal cancer. Prog Clin Biol Res 201:191–197

    PubMed  CAS  Google Scholar 

  86. The Department of Veterans Affairs Laryngeal Cancer Study Group (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685–1690

    Google Scholar 

  87. Chen AY, Schrag N, Hao Y, Flanders WD, Kepner J, Stewart A, Ward E (2006) Changes in treatment of advanced laryngeal cancer 1985–2001. Otolaryngol Head Neck Surg 135:831–837

    Article  PubMed  Google Scholar 

  88. Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T (1996) Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 88:890–899

    Article  PubMed  CAS  Google Scholar 

  89. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, Glisson B, Trotti A, Ridge JA, Chao C, Peters G, Lee DJ, Leaf A, Ensley J, Cooper J (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091–2098

    Article  PubMed  CAS  Google Scholar 

  90. Adelstein DJ, Rodriguez CP (2008) Current and emerging standards of concomitant chemoradiotherapy. Semin Oncol 35:211–220

    Article  PubMed  Google Scholar 

  91. Forastiere AA (2008) Chemotherapy in the treatment of locally advanced head and neck cancer. J Surg Oncol 97:701–707

    Article  PubMed  CAS  Google Scholar 

  92. Koness RJ, Glicksman A, Liu L, Coachman N, Landman C, Slotman G, Wanebo HJ (1997) Recurrence patterns with concurrent platinum-based chemotherapy and accelerated hyperfractionated radiotherapy in stage III and IV head and neck cancer patients. Am J Surg 174:532–535

    Article  PubMed  CAS  Google Scholar 

  93. Dequanter D, Lothaire P (2008) The role of salvage surgery in organ preservation strategies in advanced head and neck cancer. B-ENT 4:77–80

    PubMed  CAS  Google Scholar 

  94. Guadagnolo BA, Haddad RI, Posner MR, Weeks L, Wirth LJ, Norris CM, Sullivan CA, Goguen L, Busse PM, Tishler R (2005) Organ preservation and treatment toxicity with induction chemotherapy followed by radiation therapy or chemoradiation for advanced laryngeal cancer. Am J Clin Oncol 28:371–378

    Article  PubMed  Google Scholar 

  95. Rodriguez CP, Adelstein DJ, Rybicki LA, Saxton JP, Lorenz RR, Wood BG, Strome M, Esclamado RM, Lavertu P, Carroll MA (2008) Clinical predictors of larynx preservation after multiagent concurrent chemoradiotherapy. Head Neck 30:1535–1542

    Article  PubMed  Google Scholar 

  96. Cmelak AJ, Li S, Goldwasser MA, Murphy B, Cannon M, Pinto H, Rosenthal DI, Gillison M, Forastiere AA (2007) Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group study E2399. J Clin Oncol 25:3971–3977

    Article  PubMed  CAS  Google Scholar 

  97. Biete Solà A, Marruecos Querol J, Calvo Manuel FA, Verger Fransoy E, Rovirosa Casino A, Grau de Castro JJ, de Las Heras González M, Ramos Aguerri A, Palacios Eito A, Veiras Candal C, Solano López MV (2007) Phase II trial: concurrent radio-chemotherapy with weekly docetaxel for advanced squamous cell carcinoma of head and neck. Clin Transl Oncol 9:244–250

    Article  PubMed  CAS  Google Scholar 

  98. Mantz CA, Vokes EE, Kies MS, Mittal B, Witt ME, List MA, Weichselbaum RR, Haraf DJ (2001) Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer. Ann Oncol 12:343–347

    Article  PubMed  CAS  Google Scholar 

  99. Tai SK, Yang MH, Wang LW, Tsai TL, Chu PY, Wang YF, Huang JL, Chang SY (2008) Chemoradiotherapy laryngeal preservation for advanced hypopharyngeal cancer. Jpn J Clin Oncol 38:521–527

    Article  PubMed  Google Scholar 

  100. Rapidis AD, Trichas M, Stavrinidis E, Roupakia A, Ioannidou G, Kritselis G, Liossi P, Giannakouras G, Douzinas EE, Katsilieris I (2006) Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up. Oral Oncol 42:675–684

    Article  PubMed  CAS  Google Scholar 

  101. Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V, Tjulandin S, Shin DM, Cullen K, Ervin TJ, Murphy BA, Raez LE, Cohen RB, Spaulding M, Tishler RB, Roth B, Viroglio Rdel C, Venkatesan V, Romanov I, Agarwala S, Harter KW, Dugan M, Cmelak A, Markoe AM, Read PW, Steinbrenner L, Colevas AD, Norris CM Jr, Haddad RI (2007) TAX 324 Study Group. TAX 324 Study Group. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 357:1705–1715

    Article  PubMed  CAS  Google Scholar 

  102. Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M, Stewart JS, Jelic S, Betka J, Preiss JH, van den Weyngaert D, Awada A, Cupissol D, Kienzer HR, Rey A, Desaunois I, Bernier J, Lefebvre JL (2007) EORTC 24971/TAX 323 Study Group. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 357:1695–1704

    Article  PubMed  CAS  Google Scholar 

  103. Beitler JJ, Cooper JS (2009) Seduction by induction? J Clin Oncol 27:9–10

    Article  PubMed  Google Scholar 

  104. Laccourreye O, Brasnu D, Bassot V, Ménard M, Khayat D, Laccourreye H (1996) Cisplatin-fluorouracil exclusive chemotherapy for T1–T3N0 glottic squamous cell carcinoma complete clinical responders: five year results. J Clin Oncol 14:2331–2336

    PubMed  CAS  Google Scholar 

  105. Laccourreye O, Veivers D, Bassot V, Ménard M, Brasnu D, Laccourreye H (2002) Analysis of local recurrence in patients with selected T1–3N0M0 squamous cell carcinoma of the true vocal cord managed with a platinum-based chemotherapy-alone regimen for cure. Ann Otol Rhinol Laryngol 111:315–321; discussion 321–322

    PubMed  Google Scholar 

  106. Bonfils P, Trotoux J, Bassot V (2007) Chemotherapy alone in laryngeal squamous cell carcinoma. J Laryngol Otol 121:143–148

    Article  PubMed  CAS  Google Scholar 

  107. Holsinger FC, Kies MS, Diaz EM Jr, Gillenwater AM, Lewin JS, Ginsberg LE, Glisson BS, Garden AS, Ark N, Lin HY, Lee JJ, El-Naggar AK, Ki Hong W, Shin DM, Khuri FR (2009) Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancer. J Clin Oncol 27:1976–1982

    Article  PubMed  Google Scholar 

  108. Holsinger FC, Lin HY, Bassot V, Laccourreye O (2009) Platin-based exclusive chemotherapy for selected patients with squamous cell carcinoma of the larynx and pharynx. Cancer June 23 [Epub ahead of print]

  109. Forastiere AA, Shaha AR (2009) Chemotherapy alone for laryngeal preservation—is it possible? J Clin Oncol 27:1933–1934

    Article  PubMed  Google Scholar 

  110. Wheeler RH, Spencer S, Buchsbaum D, Robert F (1999) Monoclonal antibodies as potentiators of radiotherapy and chemotherapy in the management of head and neck cancer. Curr Opin Oncol 11:187–190

    Article  PubMed  CAS  Google Scholar 

  111. Pomerantz RG, Grandis JR (2004) The epidermal growth factor receptor signaling network in head and neck carcinogenesis and implications for targeted therapy. Semin Oncol 31:734–743

    Article  PubMed  CAS  Google Scholar 

  112. Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Kies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK, Ang KK (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354:567–578

    Article  PubMed  CAS  Google Scholar 

  113. Caudell JJ, Sawrie SM, Spencer SA, Desmond RA, Carroll WR, Peters GE, Nabell LM, Meredith RF, Bonner JA (2008) Locoregionally advanced head and neck cancer treated with primary radiotherapy: a comparison of the addition of cetuximab or chemotherapy and the impact of protocol treatment. Int J Radiat Oncol Biol Phys 71:676–681

    PubMed  CAS  Google Scholar 

  114. Machtay M, Moughan J, Trotti A, Garden AS, Weber RS, Cooper JS, Forastiere A, Ang KK (2008) Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 26:3582–3589

    Article  PubMed  CAS  Google Scholar 

  115. Langerman A, Maccracken E, Kasza K, Haraf DJ, Vokes EE, Stenson KM (2007) Aspiration in chemoradiated patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 133:1289–1295

    Article  PubMed  Google Scholar 

  116. Carroll WR, Locher JL, Canon CL, Bohannon IA, McColloch NL, Magnuson JS (2008) Pretreatment swallowing exercises improve swallow function after chemoradiation. Laryngoscope 118:39–43

    Article  PubMed  Google Scholar 

  117. Lawson JD, Otto K, Grist W, Johnstone PA (2008) Frequency of esophageal stenosis after simultaneous modulated accelerated radiation therapy and chemotherapy for head and neck cancer. Am J Otolaryngol 29:13–19

    Article  PubMed  Google Scholar 

  118. Ferlito A, Shaha AR, Lefebvre JL, Silver CE, Rinaldo A (2002) Organ and voice preservation in advanced laryngeal cancer. Acta Otolaryngol 122:438–442

    Article  PubMed  Google Scholar 

  119. Herranz González-Botas J, Gavilán Bouzas J (1999) Quality of life and cancer of the larynx (in Spanish). Acta Otorrinolaringol Esp 50:276–282

    PubMed  Google Scholar 

  120. Beitler JJ, Smith RV, Owen RP, Silver CE, Mazumdar M, Wadler S (2007) Phase II clinical trial of parenteral hydroxyurea and hyper-fractionated, accelerated external beam radiation therapy in patients with advanced squamous cell carcinoma of the head and neck: toxicity and efficacy with continuous ribonucleoside reductase inhibition. Head Neck 29:18–25

    Article  PubMed  Google Scholar 

  121. Smith RV, Goldman SY, Beitler JJ, Wadler SS (2004) Decreased short- and long-term swallowing problems with altered radiotherapy dosing used in an organ-sparing protocol for advanced pharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 130:831–836

    Article  PubMed  Google Scholar 

  122. Smith RV, Kotz T, Beitler JJ, Wadler SS (2000) Long-term swallowing problems after organ preservation therapy with concomitant radiation therapy and intravenous hydroxyurea: initial results. Arch Otolaryngol Head Neck Surg 126:384–389

    PubMed  CAS  Google Scholar 

  123. Dworkin JP, Hill SL, Stachler RJ, Meleca RJ, Kewson D (2006) Swallowing function outcomes following nonsurgical therapy for advanced-stage laryngeal carcinoma. Dysphagia 21:66–74

    Article  PubMed  Google Scholar 

  124. Fung K, Lyden TH, Lee J, Urba SG, Worden F, Eisbruch A, Tsien C, Bradford CR, Chepeha DB, Hogikyan ND, Prince ME, Teknos TN, Wolf GT (2005) Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer. Int J Radiat Oncol Biol Phys 63:1395–1399

    Article  PubMed  Google Scholar 

  125. Nguyen NP, Moltz CC, Frank C, Vos P, Millar C, Smith HJ, Lee H, Karlsson U, Nguyen PD, Martinez T, Nguyen LM, Sallah S (2007) Aspiration rate following nonsurgical therapy for laryngeal cancer. ORL J Otorhinolaryngol Relat Spec 69:116–120

    PubMed  Google Scholar 

  126. Hanna E, Sherman A, Cash D, Adams D, Vural E, Fan CY, Suen JY (2004) Quality of life for patients following total laryngectomy vs chemoradiation for laryngeal preservation. Arch Otolaryngol Head Neck Surg 130:875–879

    Article  PubMed  Google Scholar 

  127. Bourhis J, Le Maître A, Pignon J, Ang K, Bernier J, Overgaard J, Tobias J, Saunders M, Adelstein D, O’Sullivan B, Mach-Nc March Groups (2006) Impact of age on treatment effect in locally advanced head and neck cancer: two individual patient data meta-analyses. Proc Am Soc Clin Oncol 24(18s):5501

    Google Scholar 

  128. Clayman GL, Eicher SA, Sicard MW, Razmpa E, Goepfert H (1998) Surgical outcomes in head and neck cancer patients 80 years of age and older. Head Neck 20:216–223

    Article  PubMed  CAS  Google Scholar 

  129. Lee SC, Shores CG, Weissler MC (2008) Salvage surgery after failed primary concomitant chemoradiation. Curr Opin Otolaryngol Head Neck Surg 16:135–140

    Article  PubMed  Google Scholar 

  130. Genden EM, Ferlito A, Rinaldo A, Silver CE, Fagan JJ, Suárez C, Langendijk JA, Lefebvre JL, Bradley PJ, Leemans CR, Chen AY, Jose J, Wolf GT (2008) Recent changes in the treatment of patients with advanced laryngeal cancer. Head Neck 30:103–110

    Article  PubMed  Google Scholar 

  131. Holsinger FC, Funk E, Roberts DB, Diaz EM Jr (2006) Conservation laryngeal surgery versus total laryngectomy for radiation failure in laryngeal cancer. Head Neck 28:779–784

    Article  PubMed  Google Scholar 

  132. Miura K, Kamata SE, Kawabata K, Tada Y, Masubuti T, Nakamura N (2007) Clinical analysis of 74 cases of laryngeal cancer who underwent frontolateral partial vertical laryngectomy—usefulness of salvage surgery after failure of a full course of radiotherapy (in Japanese). Nippon Jibiinkoka Gakkai Kaiho 110:571–580

    Article  PubMed  Google Scholar 

  133. Piazza C, Peretti G, Cattaneo A, Garrubba F, De Zinis LO, Nicolai P (2007) Salvage surgery after radiotherapy for laryngeal cancer: from endoscopic resections to open-neck partial and total laryngectomies. Arch Otolaryngol Head Neck Surg 133:1037–1043

    Article  PubMed  Google Scholar 

  134. Farrag TY, Koch WM, Cummings CW, Goldenberg D, Abou-Jaoude PM, Califano JA, Flint PW, Webster K, Tufano RP (2007) Supracricoid laryngectomy outcomes: the Johns Hopkins experience. Laryngoscope 117:129–132

    Article  PubMed  Google Scholar 

  135. Lewin JS, Hutcheson KA, Barringer DA, May AH, Roberts DB, Holsinger FC, Diaz EM Jr (2008) Functional analysis of swallowing outcomes after supracricoid partial laryngectomy. Head Neck 30:559–566

    Article  PubMed  Google Scholar 

  136. Nakayama M, Okamoto M, Miyamoto S, Takeda M, Yokobori S, Masaki T, Seino Y (2008) Supracricoid laryngectomy with cricohyoidoepiglotto-pexy or cricohyoido-pexy: experience on 32 patients. Auris Nasus Larynx 35:77–82

    Article  PubMed  Google Scholar 

  137. Deganello A, Gallo O, De Cesare JM, Ninu MB, Gitti G, de’ Campora L, Radici M, de’ Campora E (2008) Supracricoid partial laryngectomy as salvage surgery for radiation therapy failure. Head Neck 30:1064–1071

    Article  PubMed  Google Scholar 

  138. Marioni G, Marchese-Ragona R, Lucioni M, Staffieri A (2008) Organ-preservation surgery following failed radiotherapy for laryngeal cancer. Evaluation, patient selection, functional outcome and survival. Curr Opin Otolaryngol Head Neck Surg 16:141–146

    Article  PubMed  Google Scholar 

  139. León X, López M, García J, Viza I, Orús C, Quer M (2007) Supracricoid laryngectomy as salvage surgery after failure of radiation therapy. Eur Arch Otorhinolaryngol 264:809–814

    Article  PubMed  Google Scholar 

  140. Laccourreye H, Laccourreye O, Weinstein G, Menard M, Brasnu D (1990) Supracricoid laryngectomy with cricohyoidopexy: a partial laryngeal procedure for selected supraglottic and transglottic carcinomas. Laryngoscope 100:735–741

    PubMed  CAS  Google Scholar 

  141. Nakayama M, Yao K, Nishiyama K, Nagai H, Ito A, Yokobori S, Okamoto M, Hirose H (2002) Swallowing function after near-total laryngectomy, cricohyoidoepiglottopexy (CHEP), and cricohyoidopexy (CHP) (in Japanese). Nippon Jibiinkoka Gakkai Kaiho 105:8–13

    PubMed  Google Scholar 

  142. Nemr NK, de Carvalho MB, Köhle J, Leite GC, Rapoport A, Szeliga RM (2007) Functional study of the voice and swallowing following supracricoid laryngectomy. Braz J Otorhinolaryngol 73:151–155

    PubMed  Google Scholar 

  143. Makeieff M, Venegoni D, Mercante G, Crampette L, Guerrier B (2005) Supracricoid partial laryngectomies after failure of radiation therapy. Laryngoscope 115:353–357

    Article  PubMed  Google Scholar 

  144. Young VN, Mangus BD, Bumpous JM (2008) Salvage laryngectomy for failed conservative treatment of laryngeal cancer. Laryngoscope 118:1561–1568

    Article  PubMed  Google Scholar 

  145. Agrawal N, Goldenberg D (2008) Primary and salvage total laryngectomy. Otolaryngol Clin North Am 41:771–780

    Article  PubMed  Google Scholar 

  146. Chen AY, Halpern M (2007) Factors predictive of survival in advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg 133:1270–1276

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Surgery and Otolaryngology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA

    Carl E. Silver

  2. Departments of Radiation Oncology, Otolaryngology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA

    Jonathan J. Beitler

  3. Head and Neck Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA

    Ashok R. Shaha

  4. Department of Surgical Sciences, ENT Clinic, University of Udine, Policlinico Universitario, Piazzale S. Maria della Misericordia, 33100, Udine, Italy

    Alessandra Rinaldo & Alfio Ferlito

Authors
  1. Carl E. Silver
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jonathan J. Beitler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ashok R. Shaha
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alessandra Rinaldo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alfio Ferlito
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alfio Ferlito.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Silver, C.E., Beitler, J.J., Shaha, A.R. et al. Current trends in initial management of laryngeal cancer: the declining use of open surgery. Eur Arch Otorhinolaryngol 266, 1333–1352 (2009). https://doi.org/10.1007/s00405-009-1028-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-009-1028-2

Keywords

Search

Navigation